The Default Mode Network (DMN), Microglia Dysfunction, and Neuropsychiatric Disorders: A Neuroimmune Interface

By SWA


The Default Mode Network (DMN) is a central player in how the human brain processes internal thoughts, memories, emotions, and self-referential thinking. Its dysfunction has been increasingly associated with a variety of psychiatric and neurological conditions, from schizophrenia to hepatic encephalopathy, and even neurodegenerative diseases like Alzheimer's. But what underlies these dysfunctions? Recent research points to an unlikely suspect: microglia, the brain's resident immune cells.



Understanding the Default Mode Network (DMN)

The DMN is most active when the brain is at rest, such as during daydreaming, self-reflection, or when not focused on external tasks. It deactivates during goal-oriented behaviors. Major hubs of the DMN include:

Medial prefrontal cortex (mPFC)

Posterior cingulate cortex (PCC)

Hippocampus

These structures are heavily involved in autobiographical memory, emotional regulation, and self-awareness.

The DMN operates as a “switchboard” — facilitating transitions between internally focused states (e.g., reflection, memory recall) and externally driven attention. It also integrates signals across brain networks, helping to coordinate memory, emotions, and cognitive control.

 

DMN Dysfunction: Symptoms and Conditions

Alterations in DMN activity or connectivity have been found in multiple disorders:

1. Schizophrenia
Cause: Disrupted integration of internal and external stimuli due to misfiring of the DMN. Symptoms: Hallucinations, disorganized thinking, social withdrawal.

Observation: Overactive DMN during tasks where it should be suppressed; this leads to excessive self-referential thoughts and intrusive internal dialogue.

2. Depression and Anxiety

Cause: Persistent negative self-referential thought and rumination, linked to hyperactivity in the DMN.

Symptoms: Depressed mood, anxiety, poor concentration, insomnia.

Observation: Increased connectivity in DMN nodes, particularly in the mPFC and PCC.

3. Hepatic Encephalopathy (HE)

A resting-state fMRI study (Zhang et al., 2019, PMC6870187) shows significant DMN abnormalities in HE patients.

Cause: Ammonia-induced neuroinflammation, astrocyte dysfunction, and impaired brain metabolism.

Symptoms: Confusion, sleepiness, mood disturbances, impaired attention.

Observation: Disrupted DMN connectivity and functional disintegration between cortical areas.

Microglia: The Immune Managers of the Brain

What Are Microglia?

Microglia are immune cells residing in the CNS, derived from monocytes that migrate from the bone marrow during development. They constantly survey the brain environment and switch between:

Resting state: Long, branched processes scan the environment.

Activated state: Amoeboid shape with fewer branches, ready for defense.

Key Microglial Functions

Immune Defense – Engulf pathogens and clear infections.

Brain Maintenance – Remove damaged neurons, prune synapses, and clear debris.

Modulation of Neural Activity – Secrete substances that regulate neuron firing and plasticity.

Phagocytosis – Swallow and digest cellular debris and invaders.

Antigen Presentation – Communicate threats to other immune cells.

The Link Between Microglial Dysfunction and DMN Abnormalities

1. Neuroinflammation and DMN Disruption

Chronic microglial activation can result in pro-inflammatory cytokine release, affecting neuronal networks including the DMN.

In conditions like depression and schizophrenia, elevated inflammatory markers correlate with altered DMN connectivity.

2. Synaptic Pruning and Memory

Microglia help fine-tune neural circuits by pruning synapses. Over-pruning due to microglial overactivation can disrupt connectivity, particularly in the hippocampus and PCC – key DMN nodes.

In Alzheimer’s disease, dysfunctional microglia fail to clear amyloid plaques, which accumulate around DMN regions and contribute to cognitive decline.

3. DMN Abnormalities in Hepatic Encephalopathy

Liver dysfunction leads to a toxic environment (e.g., ammonia buildup), triggering neuroinflammation and microglial activation.

Activated microglia disrupt astrocyte function, reduce cerebral perfusion, and impair DMN signal coherence, leading to confusion and cognitive slowing.

Microglial Overactivation: A Double-Edged Sword

While microglial activation is essential for protection, prolonged or inappropriate activation can damage healthy brain tissue and neurons, particularly in sensitive DMN hubs.

Examples:

Viral Encephalitis: Microglia detect infection, produce interferons, and phagocytose infected neurons. However, excess cytokines can cause long-term cognitive damage.

Alzheimer's Disease: Microglia fail to maintain homeostasis, contributing to amyloid buildup, tau pathology, and DMN degeneration.

Schizophrenia: Overactive synaptic pruning during adolescence, potentially microglia-driven, may weaken DMN connectivity.

Therapeutic Implications and Future Directions

1. Modulating Microglial Activity

Drugs targeting microglial activation (e.g., minocycline, P2X7 receptor inhibitors) may help reduce neuroinflammation and protect DMN integrity.

Therapies should aim for a balance, preserving microglia’s protective roles while limiting damage from overactivation.

2. Functional Neuroimaging Biomarkers

Resting-state fMRI can detect DMN abnormalities early, offering a non-invasive biomarker for psychiatric and neurological disorders.

3. Personalized Medicine

Integrating immune profiling, neuroimaging, and genetics may help personalize treatment strategies for disorders involving the DMN and microglia.

Conclusion

The Default Mode Network and microglia form a dynamic neuroimmune interface critical for brain health. While the DMN orchestrates internal mental states, microglia defend and maintain the neural environment. However, when microglia become dysregulated — through infection, toxins, or age — they can disrupt the DMN, leading to cognitive and psychiatric disorders.

Understanding this intricate relationship opens a new frontier in neuroscience and psychiatry: targeting microglial behavior to preserve or restore DMN function. It’s a promising step toward treating complex brain disorders from the inside out.

References:

Zhang LJ et al. (2019). Brain default‐mode network abnormalities in hepatic encephalopathy: A resting‐state functional MRI study. PMC6870187
https://pmc.ncbi.nlm.nih.gov/articles/PMC6870187/

Tavares G et al. (2021). The roles of microglia in viral encephalitis. PMC7802409
https://pmc.ncbi.nlm.nih.gov/articles/PMC7802409/

Song E et al. (2022). Bacteria reduce flagellin synthesis to evade microglia-astrocyte-driven immunity in the brain. ScienceDirect
https://www.sciencedirect.com/science/article/pii/S2211124722008270

Read also: 

The Default Mode Network, Microglia Dysfunction, and Psychopathy: A Neuroimmune Model of Behavioral Dysregulation
https://swaresearch.blogspot.com/2025/08/the-default-mode-network-microglia.html


© 2000-2025 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By SWA
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By SWA
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By SWA
Image
Update Oct 28th 2024:  A Novel Mouse Model for Cerebral Inflammatory Demyelination in X-Linked Adrenoleukodystrophy: Insights into Pathogenesis and Potential Therapeutic Targets https://onlinelibrary.wiley.com/doi/abs/10.1002/ana.27117 Progressive loss of cognitive abilities ""childhood dementia" and are among the rare diseases: Depending on the form of the disease, childhood neurodegeneration affects between 1 in 2,000 and 1 in 500,000 newborns. Examples include the cerebral form of X-linked adrenoleukodystrophy (X-ALD)" Very Long-Chain Fatty Acids (VLCFAs) are a specific type of fatty acid that are broken down in the body by specialized cellular structures called peroxisomes. These organelles play a critical role in maintaining metabolic balance by degrading VLCFAs. When this process is disrupted, VLCFAs accumulate in various tissues, which can lead to serious metabolic and neurological complications. Elevated VLCFA levels are characteristic of several p...
Read more